OSR Health, Inc. — Form 8-K
Filed August 19, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 92/100
What the filing says
On August 19, 2026, OSR Health received a Staff Delisting Determination from Nasdaq for failure to maintain the $1.00 minimum bid price requirement under Rule 5550(a)(2). The company has used both available 180-day compliance periods (originally notified September 5, 2025; final deadline August 31, 2026) without regaining compliance. Trading in OSRH and OSRHW will be suspended at market open August 26, 2026. The company intends to request a hearing before the Nasdaq Independent Hearings Panel, citing extraordinary trading activity on August 17–18 (370M and 145M shares traded respectively against an 18.5M public float) and a stock price that reached $0.84, only $0.16 short of the compliance threshold.
Why this rating
Delisting threat is existential for a $7.7M company. Trading suspension imminent; survival depends on Panel appeal outcome, which has uncertain probability.
See more from August 19, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.